Journal article
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
Abstract
BackgroundPatients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants significantly contribute to MOUD outcomes.ObjectivesThis systematic review aims to summarize genome-wide significant findings on MOUD outcomes and critically …
Authors
Chawar C; Hillmer A; Sanger S; D’Elia A; Panesar B; Guan L; Xie DX; Bansal N; Abdullah A; Kapczinski F
Journal
Addiction Science & Clinical Practice, Vol. 16, No. 1,
Publisher
Springer Nature
Publication Date
12 2021
DOI
10.1186/s13722-021-00278-y
ISSN
1940-0632